ArticleJournal of Alzheimer's disease & Parkinsonism2016

Targeting Alzheimer's Disease Neuro-Metabolic Dysfunction with a Small Molecule Nuclear Receptor Agonist (T3D-959) Reverses Disease Pathologies.

Ming Tong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.